Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuji Maekawa

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncoimmunology|December 10, 2013
Zoledronate-pulsed dendritic cell-based anticancer vaccinesTakashi Kamigaki, Masashi Takahara, Ryuji Maekawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer]Naomi Uchida, Hajime Yamada, Ryuji Maekawa, et al.
Journal of Neuroimmunology|June 5, 2002
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathyMayumi Ikegami, Fujio Umehara, Naohito Ikegami, et al.
Anticancer Research|January 18, 2003
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agentsKanji Hojo, Hideo Maki, Takuko Yamada Sawada, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2015
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacityMasato Muto, Muhammad Baghdadi, Ryuji Maekawa, et al.
International Journal of Oncology|September 6, 2014
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapyToshiaki Yoshikawa, Masashi Takahara, Mai Tomiyama, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
New analogue of arenastatin A, a potent cytotoxic spongean depsipeptide, with anti-tumor activityNobutoshi Murakami, Satoru Tamura, Kouhei Koyama, et al.
Clinical & Experimental Metastasis|October 31, 2002
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11Hideo Maki, Kanji Hojo, Hidekazu Tanaka, et al.
Cancer Letters|August 15, 2002
Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancerYukihiro Takeda, Tohru Wada, Yoshinori Nishitani, et al.
International Immunopharmacology|October 7, 2014
Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLsKenji Miki, Koji Nagaoka, Mitsunori Harada, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncoimmunology|December 10, 2013
Zoledronate-pulsed dendritic cell-based anticancer vaccinesTakashi Kamigaki, Masashi Takahara, Ryuji Maekawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer]Naomi Uchida, Hajime Yamada, Ryuji Maekawa, et al.
Journal of Neuroimmunology|June 5, 2002
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathyMayumi Ikegami, Fujio Umehara, Naohito Ikegami, et al.
Anticancer Research|January 18, 2003
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agentsKanji Hojo, Hideo Maki, Takuko Yamada Sawada, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2015
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacityMasato Muto, Muhammad Baghdadi, Ryuji Maekawa, et al.
International Journal of Oncology|September 6, 2014
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapyToshiaki Yoshikawa, Masashi Takahara, Mai Tomiyama, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
New analogue of arenastatin A, a potent cytotoxic spongean depsipeptide, with anti-tumor activityNobutoshi Murakami, Satoru Tamura, Kouhei Koyama, et al.
Clinical & Experimental Metastasis|October 31, 2002
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11Hideo Maki, Kanji Hojo, Hidekazu Tanaka, et al.
Cancer Letters|August 15, 2002
Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancerYukihiro Takeda, Tohru Wada, Yoshinori Nishitani, et al.
International Immunopharmacology|October 7, 2014
Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLsKenji Miki, Koji Nagaoka, Mitsunori Harada, et al.
Pageof 3